Two chemicals produced by gut bacteria, PAA and PPA, have opposite effects on metabolism depending on your sex, according to research reviewed by Gram. In mice, PAA improved blood sugar control in males and reduced blood fat levels in both sexes by activating fat-burning pathways in the liver, while PPA increased fat storage in females but improved glucose control in males. These findings suggest that future treatments for metabolic disease may need to be personalized based on both the specific bacterial chemicals involved and whether you’re male or female.
Your gut bacteria produce special chemicals that affect how your body handles weight, blood sugar, and fat. A new study found that two similar chemicals called PAA and PPA have surprisingly different effects, and these effects depend on whether you’re male or female. Researchers tested these chemicals in mice with obesity and discovered that PAA improved blood sugar control in males and changed how the body processes fat in both sexes, while PPA had opposite effects. According to Gram Research analysis, these findings suggest that personalized treatments for weight and metabolic problems may need to account for both the specific bacterial chemicals involved and a person’s sex.
Key Statistics
A 2026 research study in mice found that phenylacetic acid (PAA), a chemical produced by gut bacteria, improved glucose tolerance in male mice and reduced circulating triglycerides and acylcarnitines in both sexes by activating liver fat-burning pathways.
According to a 2026 mouse study, phenylpropionic acid (PPA), a structurally similar bacterial metabolite, produced opposite sex-dependent effects: increasing fat storage in female mice while improving glucose tolerance in male mice.
A 2026 preprint study demonstrated that PAA extensively remodeled lipid metabolism and activated hepatic PPAR-alpha-associated gene programs without causing liver damage, fatty liver disease, or markers of liver injury in obese mice.
The Quick Take
- What they studied: How two different chemicals made by gut bacteria affect body weight, blood sugar, and fat metabolism, and whether these effects differ between males and females
- Who participated: Mice with diet-induced obesity were used as the study model to test the effects of phenylacetic acid (PAA) and phenylpropionic acid (PPA), two metabolites produced by gut bacteria
- Key finding: PAA improved glucose control in male mice and changed fat metabolism in both sexes by reducing blood triglycerides and activating fat-burning pathways in the liver, while PPA had opposite sex-dependent effects, increasing fat storage in females but improving glucose control in males
- What it means for you: Future treatments for weight and metabolic problems may need to be personalized based on which gut bacteria chemicals are involved and your biological sex. However, this is early research in mice, so human studies are needed before applying these findings to people
The Research Details
Researchers used mice that had been fed a high-fat diet to become obese, mimicking how obesity develops in humans. They then gave some mice PAA and others PPA, two chemicals that are naturally produced by gut bacteria. The scientists measured multiple aspects of the mice’s health, including body weight, blood sugar levels, fat storage, and liver function. They also examined how genes in the liver were turned on or off in response to these chemicals, looking specifically at pathways related to fat burning and metabolism.
This type of study is called a mechanistic research study because it focuses on understanding how specific molecules work in the body rather than testing a treatment in humans. The researchers used advanced techniques to measure changes in gene expression and metabolic markers, allowing them to see exactly which biological pathways were affected by each chemical.
The study design allowed researchers to isolate the effects of individual bacterial metabolites, which is important because the gut produces hundreds of different chemicals. By testing PAA and PPA separately, they could determine whether structurally similar molecules have similar or different effects on metabolism.
Most research on gut bacteria focuses on the bacteria themselves, but bacteria actually communicate with the body through chemicals they produce. Understanding how individual chemicals work is crucial for developing targeted treatments that could help people with obesity and metabolic disease. This research is particularly important because it shows that one-size-fits-all treatments may not work, and that sex differences need to be considered when designing therapies.
This is a preliminary study published on a preprint server, meaning it has not yet been peer-reviewed by independent experts. The research was conducted in mice, which are useful for understanding basic biological mechanisms but do not always translate directly to humans. The study provides detailed molecular analysis, which strengthens the findings, but human clinical trials would be needed to confirm whether these effects occur in people. The fact that the researchers found sex-dependent effects is noteworthy because it suggests the findings are specific and not just random variation.
What the Results Show
PAA produced the most dramatic metabolic changes. In male mice, PAA improved how their bodies handled blood sugar, meaning their glucose tolerance improved. In both male and female mice, PAA reduced the amount of triglycerides (a type of fat) circulating in the blood and decreased acylcarnitines (molecules involved in fat transport). The liver showed increased activity of genes related to fat burning, specifically pathways that break down fatty acids through a process called omega-hydroxylation and peroxisomal metabolism.
Despite these extensive changes in fat metabolism, PAA did not cause liver damage or fatty liver disease, which was an important finding because some metabolic changes can harm the liver. The chemical essentially rewired how the body processes fat without causing harm.
PPA, the structurally similar chemical, had very different effects. It did not significantly affect the liver’s fat-burning pathways. Instead, it produced sex-dependent effects on body composition and glucose control. In female mice, PPA increased fat storage (adiposity), while in male mice, it improved glucose tolerance similar to PAA. This demonstrates that even small structural differences between bacterial metabolites can lead to completely different biological outcomes.
The study found that PAA did not change overall body weight or total fat storage in either sex, despite its effects on fat metabolism and blood triglycerides. This suggests that PAA changes how the body processes fat without necessarily reducing total fat stores. The liver’s gene expression patterns revealed activation of specific metabolic pathways, particularly those related to peroxisomal function and fatty acid oxidation, indicating that PAA fundamentally alters how liver cells handle fats. The lack of liver injury markers despite these metabolic changes suggests PAA’s effects are metabolically beneficial rather than toxic.
Previous clinical studies in humans have linked PAA and its related compound phenylacetylglutamine to metabolic disease, suggesting these chemicals might be harmful. This new research suggests the relationship is more complex than previously thought. The findings align with growing recognition that gut bacterial metabolites play important roles in metabolism, but they challenge the assumption that all metabolites associated with disease are directly causing harm. The sex-dependent effects observed here are consistent with emerging evidence that metabolic responses to dietary and microbial factors often differ between males and females, though this area remains understudied.
This study was conducted in mice, not humans, so the results may not directly apply to people. The specific genetic background of laboratory mice may not represent the diversity of human genetics. The study did not examine whether these effects occur with natural levels of these chemicals produced by the gut microbiota or only at the doses administered in the experiment. The research does not explain the biological mechanisms behind why these chemicals have sex-dependent effects, only that they do. Additionally, the study was published as a preprint and has not yet undergone peer review by independent scientists.
The Bottom Line
Based on this research, there are no direct recommendations for people at this time. The findings suggest that future treatments for metabolic disease should consider both the specific bacterial metabolites involved and a person’s biological sex. If you have concerns about your gut health or metabolic health, consult with a healthcare provider about evidence-based approaches such as dietary changes, exercise, and medical management. Do not attempt to self-treat based on this preliminary research.
Researchers studying gut bacteria and metabolism should pay attention to these findings because they demonstrate that individual bacterial metabolites have distinct effects. People with obesity or metabolic disorders may eventually benefit from personalized treatments based on their gut bacterial profiles and sex, but this is not yet available. Healthcare providers developing new treatments for metabolic disease should consider these findings when designing future therapies.
This is basic research aimed at understanding biological mechanisms, not a treatment being tested in humans. It typically takes 5 to 10 years or more for findings from animal studies to lead to human clinical trials, and several more years for treatments to become available. Realistic expectations are that this research will inform future studies over the next several years.
Frequently Asked Questions
Do gut bacteria chemicals affect weight loss differently in men and women?
Research shows that bacterial metabolites like PAA and PPA have sex-dependent effects on metabolism. A 2026 mouse study found PPA increased fat storage in females but improved glucose control in males, suggesting personalized approaches may be needed based on biological sex.
Can phenylacetic acid from gut bacteria help with blood sugar control?
In a 2026 mouse study, phenylacetic acid improved glucose tolerance specifically in male mice and reduced blood triglycerides in both sexes by activating fat-burning pathways in the liver, though human studies are needed to confirm these effects.
Are gut bacterial metabolites safe for liver health?
A 2026 research study found that phenylacetic acid, despite dramatically changing fat metabolism, did not cause liver damage, fatty liver disease, or liver injury markers in obese mice, suggesting these metabolic changes can occur without harming the liver.
How do I increase beneficial gut bacteria that produce these metabolites?
While this research doesn’t specify which bacteria produce PAA and PPA, general strategies include eating more fiber from vegetables and whole grains, consuming fermented foods, and avoiding excessive processed foods. Consult your doctor before making major dietary changes.
When will treatments based on gut bacterial metabolites be available?
This is early-stage research in mice published in 2026. Typically, it takes 5 to 10 years for animal research to lead to human clinical trials. Personalized treatments based on bacterial metabolites are likely several years away from becoming available to patients.
Want to Apply This Research?
- Track daily blood sugar levels (if you have access to a glucose monitor), triglyceride levels from blood tests, and body composition changes monthly. Note any dietary changes that might affect gut bacteria, such as fiber intake or fermented foods, to correlate with metabolic markers.
- Increase dietary fiber intake from vegetables, fruits, and whole grains to support the growth of beneficial gut bacteria that produce these metabolites. Monitor how different foods affect your energy levels and blood sugar stability using the app’s food and symptom logging features.
- Establish a baseline of your current metabolic markers through blood work with your doctor. Then track changes in weight, energy levels, and blood sugar patterns monthly while making gradual dietary improvements. Share these trends with your healthcare provider to identify patterns related to your individual response to dietary changes.
This research was conducted in mice and has not yet been peer-reviewed. The findings do not constitute medical advice and should not be used to diagnose, treat, or prevent any disease. Consult with a qualified healthcare provider before making changes to your diet or starting any new treatment, especially if you have existing metabolic conditions, take medications, or have concerns about your health. This article is for educational purposes only and is not a substitute for professional medical guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.